What are we aiming for?

Similar documents
Developing Key Messages on Cancer for Commissioners

Developing Key Messages on Cancer for Commissioners

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

National Cancer Update. Stephen Parsons Director

Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network

The Late Consequences of Cancer Treatment The Impact & Management of the Late Effects of Pelvic Cancer Treatments

National Breast Cancer Audit next steps. Martin Lee

BACKGROUND TO THE HEALTH AND WELLBEING STRATEGY. Neil Revely

Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.

Haemato-oncology Clinical Forum. 20 th June 2013

Progress on cancer survivorship. Stephen Hindle Cancer Survivorship Programme Lead

Acute Oncology & Chemotherapy Clinical Network Group (CNG)

An Integrated National Strategy for Breast Cancer Audit. Martin Lee Gill Lawrence

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013

Ensuring effective commissioning of cancer services: A survey of GPs

Lung Cancer and Rehabilitation

NCIN Conference Feedback 2015

WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

National Cancer Programme: Living With and Beyond Cancer

Dr David Geddes. Head of Primary Care Commissioning. LDC Officials Day. 6 December 2013

Cancer Transformation Programme

National Cancer Programme: Living With and Beyond Cancer. Becky Clack Programme Manager, NHS England. September

ROLE SPECIFICATION FOR MACMILLAN GPs

The role of cancer networks in the new NHS

The NHS Cancer Plan: A Progress Report

Throwing light on the consequences of cancer and its treatment

Cheshire and Merseyside Cancer Alliance. Helen Porter Director of Nursing and Quality 19 th April 2017

National Cancer Programme. Work Plan 2015/16

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead

Number of people with diabetes

National Cancer Programme. Work Plan 2014/15

Health Board/Region: All-Wales

Cost-effective commissioning of colorectal cancer care: An assessment of the cost-effectiveness of improving early diagnosis

Cancer Research UK response to All Party Parliamentary Group on Cancer consultation Cancer across the Domains

Wessex Cancer Alliance. Wessex Cancer Strategic Clinical Network

The Prime Minister s Challenge on Dementia. Lorraine Jackson Deputy Director: Domestic Dementia Policy Department of Health

Ruth Howkins Deputy National Coordinator National Cancer Peer Review

HIV in London: A Complexity Challenge

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England

HC 568 SesSIon november Department of Health. Delivering the Cancer Reform Strategy

Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015

CANCER: SHIFTING GEARS. line with the best in Europe

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

Cancer Outcomes and Services Dataset: Implications for clinical teams

Integrated Diabetes Care in Oxfordshire -patient's perspective. Avril Surridge

Cancer Campaigning Group response to the consultation on the review of the Cancer Reform Strategy

Report by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report

Dorset Cancer Alliance:

MCIP Recruitment Pack

Survivorship Guidelines. September 2013 (updated August 2015)

In this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care

Colorectal Pathway Meeting minutes Wednesday 16 th July 2014, 2 pm 4 pm Nightingale Lecture Theatre, UHSM

Identifying and counting people living with treatable but not curable cancer

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK

Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer

Improving Outcomes: A Strategy for Cancer

NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY

Commissioning Urology Services in New NHS

An Overview of Health Economics Data and Expertise in Cancer

GOVERNING BODY REPORT

BETTER CANCER CARE AND THE FUTURE PROVISION OF CANCER CARE IN NHS LANARKSHIRE

The Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016

Cancer Screening Nottingham City Joint Strategic Needs Assessment April 2009

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1

NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit

National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce

Cancer Delivery Plan. April Abertawe Bro Morgannwg University Health Board

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

National Cancer Peer Review Programme

National Cancer Survivorship Initiative

Six step guide to improving diabetes footcare. Putting feet. first

PRIMARY CARE CO-COMMISSIONING COMMITTEE. 9 June 2015

Defining quality in ovarian cancer services: the patient perspective

Transforming Cancer Services for London

On-going and planned colorectal cancer clinical outcome analyses

National Prostate Cancer Audit. Bill Cross June 2015

Vacancy list Pathway Boards

Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology

Commissioning Guidance: Thames Valley & Milton Keynes Strategic Clinical Network. Cancer. September 2016

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Ovarian Cancer Australia submission to the Senate Select Committee into Funding for Research into Cancers with Low Survival Rates

Waiting Times for Suspected and Diagnosed Cancer Patients

Enhanced Supportive Care. Dr Joanna Sheppard Dr Jane Neerkin

Cancer across the Domains. Cancer priorities for the new NHS

The Idle Valley Ecominds project and commissioning experience. Dominic Higgins, Nature & Wellbeing Manager, The Wildlife Trusts

Proposed Neurosciences National Structure. Accountability Framework Neurological Alliance (Feedback Loop) National Advisory Group (Neurosciences)

ANNUAL CANCER DELIVERY ACTION PLAN REPORT

NCIN Breast Cancer Workshop 13 March 2014 Hilton Metropole, NEC, Birmingham. Kieran Horgan, Dick Rainsbury, Mark Sibbering, Gill lawrence

Miles Briggs (The Chair) opened the meeting and welcomed the attendees and speakers to the meeting.

Kingston Cancer Strategy

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Board

Palliative care services and home and community care services inquiry

That the Single Commissioning Board supports the project outlined in this report and proceeds as described.

London Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018

REPORT TO CLINICAL COMMISSIONING GROUP

CANCER LEADERSHIP COUNCIL

Transcription:

The Priorities for Cancer Services Stephen Parsons Director What are we aiming for? Our aspiration is that England should achieve cancer outcomes which are comparable with the best in the world 1

Outline of Presentation Addressing Priorities within the context of: NHS Reforms Financial challenge The Information Revolution NHS Outcomes Framework Health Service Reforms Parliament: The Bill NHS Commissioning Board Public Health England CCGs Networks and Senates The Improvement Body 2

Financial Challenge The need to achieve efficiency savings of up to 20 billion, to be reinvested in services to provide high-quality care. NAO commented on a lack of understanding of what drives costs in cancer care, particularly in radiotherapy, chemotherapy and the location of care. There is a need: for better information on the cost of services to identify areas for investment to identify areas for disinvestment The Information Revolution and Cancer (1) We are giving high priority to Measuring outcomes Measuring processes linked to outcomes Making information widely available Cancer Registry Modernisation Programme A single system (Encore) across England by end 2012 This will improve both timeliness of registration and completeness of case ascertainment Accurate/comparable staging to be available on at least 70% of cancer patients (over 90% of cases for those cancers deemed stageable ) 3

The Information Revolution and Cancer (2) Improved data collection e.g. New analyses e.g. Improved outputs e.g. Cancer outcomes and services dataset chemotherapy dataset Emergency presentations; survivorship; costs; mental health and cancer PCT profiles; GP practice profiles; service profiles (breast, colorectal, RT) NHS Outcomes Framework 5 Domains: 1. Reducing mortality and improving survival 2. Improving quality of life 3. Enhancing recovery 4. Improving patients experience of care 5. Improving safety 4

Save Lives (1) 1. The Incidence is rising: - 265,000 new cases p.a. now; 300,000 by 2030. 2. Cancer services and outcomes (survival and mortality) have improved over the past 10 15 years. Much of the improvement has been in the hospital sector (MDTs etc). 3. Despite this, survival for many cancers remains poor in comparison with other developed countries. 5000 lives a year could be saved if we matched the European average. 10,000 lives a year could be saved if we achieved the level of the best. 4. Late diagnosis is the major factor underlying the poor survival rates in this country. Save Lives (2) 5. This is not simply a matter of patients living a few extra months. It can often be the difference between early death and long term survival/cure. 6. Initiatives to promote early diagnosis are likely to be highly cost effective. 7. Particular attention should be given to: Reducing emergency presentations (around 25% of all cancers) as these have very poor survival The elderly who often present late Ensuring that providers record staging and report this to their cancer registry 5

Reducing mortality and improving survival (1) NAEDI Awareness campaigns Supporting GPs on earlier diagnosis Improving access to diagnostics Endoscopy, endoscopy, endoscopy Focus on emergency presentations Reducing mortality and improving survival (2) National lung campaign - May and June Top-up of national bowel campaign September National work to support primary care/diagnostics, etc Regional campaigns - January to March 2013: Blood in urine Either breast cancer in over 70s or oesophagogastric Trial a regional campaign without TV? 6

Reducing mortality and improving survival (3) Proposed Local Activities GP leadership and engagement Additional resources for each Network to support national and regional campaigns New "sites" for bids: ovarian constellation of symptoms Increase stretch of national and regional campaigns, e.g. to run local activity after the bursts of TV advertising have finished New approaches to raising awareness on any of the tumour sites that have already been covered Improving quality of life (1) We want to see improvements in the outcomes which are particularly relevant for people living with and beyond cancer, such as: reducing ill health associated with cancer treatment; reducing risks of recurrent cancer; reducing the proportion of people who report unmet physical or psychological support needs following cancer treatment; increasing the proportion of cancer survivors of working age who are able to work who are in work; 7

Improving quality of life (2) Ongoing work Treatment summaries and care plans (tailored/risk stratified) Health and well being clinics Rehabilitation and exercise programmes Support for self management Alternatives to routine follow up (e.g. Remote monitoring for patients in clinical remission) Late effects services New models for active and advanced disease Costing studies Enhancing recovery Ensuring that all cancer patients receive the appropriate treatment, delivered to a high standard, is critical to improving cancer outcomes Promote the uptake of the latest surgical techniques, ensuring that the existing surgical workforce receives appropriate training to do this e.g. Laparoscopic colorectal surgery Improve intervention rates for older people who could benefit, ensuring that age alone is never a barrier to the most appropriate treatment Enhanced Recovery Programmes spreading good practice Increased day/overnight breast surgery Reducing unnecessary admissions (emergency and elective) and reducing length of stay have the greatest potential to improve quality and productivity 8

2010 Cancer Patients Experience Survey Improving patients experience of care Multiple actions are needed at MDT level to address deficiencies indentified by the Cancer Patient Experience Survey Information prescriptions Communication skills training Better MDT working (MDT-FIT) Important role of clinical nurse specialists Need to turn Red teams Green This has implications for all cancer types (and beyond cancer) 9

Improving safety Measuring safety (e.g. 30 day mortality after surgery, radiotherapy, chemotherapy) Ensuring safety e.g. Chemotherapy Elective chemotherapy (NRAG report) Acute oncology services Peer review e.g. Acting on immediate risks and serious concerns Summary We are making steady progress on cancer generally However we still have a long way to go We have to retain a focus on the key priorities to ensure that we continue to make progress despite all the uncertainties and the financial constraints 10